Phase II Multi-Institutional Study of Low-Dose (2Gy x 2) Palliative Radiotherapy in the Treatment of Symptomatic Bone metastases from Multiple Myeloma
Recruiting
99 years or below
All
Phase
2
20 participants needed
1 Location
Brief description of study
Please see page 4 of the attached protocol
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
Updated on
09 Sep 2020.
Study ID: 833880